Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Gurdeep Mannu from the Nuffield Department of Population Health has won the Office for National Statistics (ONS) Research Excellence Award for a study which highlighted early risk factors for breast cancer patients.

breast examination

The study looked at more than 25 years of data on women receiving different breast cancer treatments, has been recognised by the ONS in its Research Excellence Awards for its insight and its important implications for management of patients with this kind of early-stage breast cancer in the future.   

Dr Gurdeep Mannu’s research showed that women who are diagnosed with ductal carcinoma in situ (an early-stage breast cancer) during breast screening go on to experience higher risks of developing invasive breast cancer and of death from breast cancer, compared with the general population. 

The research looked at data on 35,000 women in England diagnosed as having ductal carcinoma in situ by the NHS Breast Screening Programme from 1988 to 2014. It combined ONS mortality data with Hospital Episode Statistics from NHS Digital to show that the rate of women later developing invasive breast cancer was more than double what was expected, while mortality rates were 70% higher than expected. 

These findings will have important implications for management of patients with this kind of early-stage breast cancer in the future. 

The full story is on the Nuffield Department of Population Health website

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.